Results 101 to 110 of about 32,769 (202)

Criteria for Dose Adjustment of Tildrakizumab in Psoriasis Vulgaris

open access: yes
JEADV Clinical Practice, EarlyView.
Andreas Pinter   +2 more
wiley   +1 more source

Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Although the data on psoriasis epidemiology included in the Global Psoriasis Atlas (GPA) provide valuable information on psoriasis prevalence worldwide, the GPA database is still incomplete. Therefore, the aim of the study was to assess the prevalence, incidence, and mortality rates of psoriasis and its types in Poland based on the ...
Joanna Bartosińska   +10 more
wiley   +1 more source

Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. [PDF]

open access: yesFront Med (Lausanne), 2021
Bhushan V   +11 more
europepmc   +1 more source

Challenging the Dogma That Psoriasis Skin Lesions Occur Before Arthritis

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Psoriasis skin lesions are generally thought to occur before psoriatic arthritis (PsA) develops. However, PsA may be challenging to diagnose in the absence of psoriasis and might be underdiagnosed when occurring before psoriasis.
Hannah Y. Gantz   +9 more
wiley   +1 more source

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis

open access: yesBiologics: Targets & Therapy, 2014
Dario Kivelevitch, Bobbak Mansouri, Alan Menter Department of Dermatology, Baylor University Medical Center, Dallas, TX, USA Abstract: Psoriasis is a chronic, immune-mediated inflammatory disease affecting both the skin and joints.
Kivelevitch D, Mansouri B, Menter A
doaj  

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study. [PDF]

open access: yesJ Clin Med, 2022
D'Angelo S   +30 more
europepmc   +1 more source

Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real‐Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola   +12 more
wiley   +1 more source

Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options

open access: yesPsoriasis: Targets and Therapy, 2013
Muhammad Haroon,1 Oliver FitzGerald,1 Robert Winchester2 1Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland; 2Division of Rheumatology, Columbia University College of Physicians and Surgeons, New York, NY, USA Abstract ...
Haroon M, FitzGerald O, Winchester R
doaj  

Decoding the Prescriber: Dermatology Versus Rheumatology Approaches

open access: yes
Australasian Journal of Dermatology, EarlyView.
Nicole Kah Mun Yoong   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy